# Early Administration of L-carnitine in Hemodialysis Patients

> **NCT00322322** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 110 (actual)

## Conditions studied

- Complication of Hemodialysis
- Hyperthyroidism Treated or Under Control

## Interventions

- **DRUG:** L-Carnitine

## Key facts

- **NCT ID:** NCT00322322
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2011-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00322322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00322322, "Early Administration of L-carnitine in Hemodialysis Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00322322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*